Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Cardiovasc Res. 2020 Apr 1;116(5):970-982. doi: 10.1093/cvr/cvz192.
Cardiovasc Res. 2020.
PMID: 31346605
Free article.